Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

At Dec. 31, Anavex had $143 million in cash and 82 million shares outstanding. That’s $1.80 a share in cash at year end. The stock closed today at $3.39. That means the market is valuing Anavex’s pipeline, technology, and patents at $1.59 a share.

Not exactly a ringing endorsement for what the WGTers believe will be the world’s first trillion dollar drug.